Johnson & Johnson posts earnings of $1.50 a share vs. $1.44 a share estimate

Analysts had expected Johnson& Johnson to report earnings excluding items of $1.44 a share on $18.37 billion in revenue, according to a consensus estimate from Thomson Reuters.. At the end of September, Johnson& Johnson announced plans to buy Alios BioPharma, a biotech company focused on developing existing therapies for viral diseases. In the wake of the latest...